Drug Profile


Alternative Names: IQB 837V; IQB 852; IQB 872

Latest Information Update: 22 Jul 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator IQB
  • Class Antihypertensives; Dihydropyridines; Small molecules
  • Mechanism of Action Calcium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Hypertension; Ischaemic heart disorders

Most Recent Events

  • 22 Jul 2011 Discontinued - Phase-II for Hypertension in United Kingdom (PO)
  • 22 Jul 2011 Discontinued - Phase-III for Hypertension in France (PO)
  • 22 Jul 2011 Discontinued - Phase-III for Hypertension in Germany (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top